Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC

Researchers evaluated the survival benefit of adding pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab –paclitaxel compared with chemotherapy alone. (Source: CancerNetwork)

from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2EtM91C
via IFTTT